About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
DVAX - Dynavax Technologies...| Previous Close | $9.18 | Open | $9.11 |
| Volume | 4.32M | Market Cap | 846.25M |
| Yield | Last Dividend |
| BRIEF-Dynavax Tech, Times Pharmacy Annou... | 07/10/20 |
| Dynavax Technologies Corp: | |
| The Daily Biotech Pulse: Ziopharm Starts... | 07/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affi... | |
| Thinking about trading options or stock ... | 06/26/20 |
| NEW YORK, June 26, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AXSM, SPCE, DVAX, BIG, and DIS. Click a link below the... | |
| Thinking about buying stock in Trevena, ... | 06/24/20 |
| NEW YORK, June 24, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TRVN, TBIO, WKHS, DVAX, and SEEL. To see how Investors... | |
| Dynavax to Present at the H.C. Wainwrigh... | 06/22/20 |
| EMERYVILLE, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developi... | |
| Thinking about buying stock in Salem Med... | 06/19/20 |
| NEW YORK, June 19, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SALM, DVAX, CLSN, HTZ, and MGM. To see how InvestorsOb... | |
| Dynavax Closes Enrollment in Renal Disea... | 06/10/20 |
| Dynavax (DVAX) is developing its hepatitis B vaccine, Heplisav-B, in patients with end-stage renal disease undergoing hemodialysis in a phase I study. | |
| Thinking about buying stock in Laredo Pe... | 06/02/20 |
| NEW YORK, June 2, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LPI, MGI, DVAX, RIOT, and AESE. To see how InvestorsObs... | |
| The Daily Biotech Pulse: FDA Nod For Roc... | 06/02/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Adap... | |
| Dynavax Technologies Announces Proposed ... | 05/21/20 |
| EMERYVILLE, Calif., May 21, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developin... | |
| Biotech Stock Roundup: MRNA, DVAX Up on ... | 05/20/20 |
| The biotech sector remains in focus with pipeline updates on coronavirus treatments. | |
| Why Dynavax Technologies (DVAX) Stock Mi... | 05/14/20 |
| Dynavax Technologies (DVAX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. | |
| Dynavax Technologies (DVAX) in Focus: St... | 04/17/20 |
| Dynavax Technologies (DVAX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes. | |
| The Daily Biotech Pulse: Roche Obtains F... | 03/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) ... | |
| Dynavax Technologies (DVAX) May Report N... | 03/04/20 |
| Dynavax Technologies (DVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get pr... | |
| Is the Options Market Predicting a Spike... | 12/03/19 |
| Investors need to pay close attention to Dynavax (DVAX) stock based on the movements in the options market lately. | |
| Dynavax Technologies (NASDAQ:DVAX) Downg... | 11/08/19 |
| Dynavax Technologies (NASDAQ:DVAX) was downgraded by equities researchers at BidaskClub from a ???buy??? rating to a ???hold??? rating in a report iss... | |
| Dynavax Technologies (DVAX) Expected to ... | 10/30/19 |
| Dynavax Technologies (DVAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared... | |
| Dynavax Technologies Corporation (DVAX) ... | 08/19/19 |
| As of late, it has definitely been a great time to be an investor in Dynavax Technologies Corporation (DVAX). | |
| Dynavax Technologies (DVAX) Reports Q2 L... | 08/07/19 |
| Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -4.76% and 4.94%, respectively, for the quarter ended June 2019. Do the number... | |
| The Daily Biotech Pulse: Obseva Gets The... | 07/26/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 25) ... | |
| The Daily Biotech Pulse: Setback For Bri... | 07/25/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 24) ... | |
| The Daily Biotech Pulse: Jounce Jumps On... | 07/24/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 23) ... | |
| Dynavax Technologies Sees Hammer Chart P... | 07/19/19 |
| Dynavax Technologies Corporation (DVAX) has been struggling lately, but the selling pressure may be coming to an end soon. | |
| The Daily Biotech Pulse: Vertex Bets Big... | 06/07/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 6) B... | |
| Dynavax Technologies Corporation (DVAX) ... | 06/04/19 |
| The following slide deck was published by Dynavax Technologies Corporation in conjunction with this event. | |
| The Daily Biotech Pulse: ASCO Presentati... | 06/04/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 3) A... | |
| The Daily Biotech Pulse: Merrimack To St... | 05/31/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 30) A... | |
| Here's Why Dynavax Technologies Is Tumbl... | 05/24/19 |
| The company's latest restructuring announcement isn't sitting well with investors. | |
| Investors warm to Dynavax reboot; shares... | 05/24/19 |
| No summary available. | |
| Date | 2020-05-07 (AMC) | Est. (EPS/Rev.) | ($0.31)/ 11.36M |
| Actual (EPS/Rev.) | $-0.25/ $10.92 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| 1035even | Evan Earle | 61.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
